Equities researchers at Guggenheim began coverage on shares of Tempus AI (NASDAQ:TEM - Get Free Report) in a research note issued to investors on Monday, Marketbeat.com reports. The firm set a "buy" rating and a $74.00 price target on the stock. Guggenheim's price target points to a potential upside of 59.14% from the stock's previous close.
Other research analysts have also issued reports about the stock. Piper Sandler reissued a "neutral" rating and set a $70.00 target price (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Bank of America cut shares of Tempus AI from a "buy" rating to a "neutral" rating and increased their price objective for the stock from $45.00 to $60.00 in a research report on Wednesday, October 2nd. Loop Capital boosted their target price on Tempus AI from $48.00 to $57.00 and gave the company a "buy" rating in a research report on Tuesday, October 15th. Finally, Stifel Nicolaus downgraded Tempus AI from a "buy" rating to a "hold" rating and upped their price target for the stock from $45.00 to $65.00 in a research note on Monday, November 11th. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to MarketBeat.com, Tempus AI currently has a consensus rating of "Moderate Buy" and a consensus price target of $56.20.
Read Our Latest Research Report on Tempus AI
Tempus AI Price Performance
Shares of Tempus AI stock traded down $3.94 on Monday, reaching $46.50. 2,923,812 shares of the company's stock were exchanged, compared to its average volume of 1,231,831. The business has a 50-day moving average price of $53.54. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI has a 52 week low of $22.89 and a 52 week high of $79.49.
Institutional Trading of Tempus AI
Institutional investors and hedge funds have recently modified their holdings of the stock. First Horizon Advisors Inc. bought a new stake in Tempus AI during the third quarter worth $30,000. Vestor Capital LLC purchased a new position in Tempus AI during the 3rd quarter worth $153,000. Stifel Financial Corp bought a new stake in shares of Tempus AI in the 3rd quarter worth $218,000. Sandia Investment Management LP purchased a new stake in shares of Tempus AI in the second quarter valued at about $136,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new position in shares of Tempus AI during the third quarter valued at about $258,000. 24.22% of the stock is owned by hedge funds and other institutional investors.
About Tempus AI
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
